Simon F. Campbell

3.0k total citations
54 papers, 1.9k citations indexed

About

Simon F. Campbell is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Simon F. Campbell has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Organic Chemistry, 22 papers in Molecular Biology and 9 papers in Pharmaceutical Science. Recurrent topics in Simon F. Campbell's work include Synthesis and Biological Evaluation (11 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Fluorine in Organic Chemistry (7 papers). Simon F. Campbell is often cited by papers focused on Synthesis and Biological Evaluation (11 papers), Phenothiazines and Benzothiazines Synthesis and Activities (9 papers) and Fluorine in Organic Chemistry (7 papers). Simon F. Campbell collaborates with scholars based in United Kingdom, Brazil and United States. Simon F. Campbell's co-authors include Janet M. Thornton, Simon J. Hubbard, Michael Palmer, Peter E. Cross, Roger A. Burges, Donald G. Gardiner, Kenneth J. Blackburn, Philip Kocieński, John Arrowsmith and R. Stephens and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Molecular Biology.

In The Last Decade

Simon F. Campbell

54 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Simon F. Campbell 833 791 191 179 166 54 1.9k
Michael Czarniecki 646 0.8× 642 0.8× 105 0.5× 98 0.5× 145 0.9× 46 1.3k
B. CASTRO 1.6k 1.9× 890 1.1× 83 0.4× 93 0.5× 154 0.9× 63 2.1k
Bertrand Castro 1.7k 2.0× 1.1k 1.4× 169 0.9× 57 0.3× 177 1.1× 76 2.5k
Th. Wieland 1.0k 1.2× 391 0.5× 91 0.5× 86 0.5× 319 1.9× 87 2.1k
David C. Pryde 1.1k 1.3× 689 0.9× 65 0.3× 118 0.7× 76 0.5× 74 2.3k
David C. Rees 1.2k 1.4× 1.5k 2.0× 311 1.6× 86 0.5× 204 1.2× 16 3.1k
Thomas J. Perun 678 0.8× 612 0.8× 55 0.3× 95 0.5× 133 0.8× 48 1.4k
Zsolt Böcskei 704 0.8× 550 0.7× 197 1.0× 40 0.2× 177 1.1× 69 1.8k
H. C. J. OTTENHEIJM 1.9k 2.3× 1.9k 2.4× 67 0.4× 108 0.6× 156 0.9× 121 2.9k
Stephen W. Kaldor 1.2k 1.4× 1.4k 1.7× 75 0.4× 44 0.2× 88 0.5× 36 2.6k

Countries citing papers authored by Simon F. Campbell

Since Specialization
Citations

This map shows the geographic impact of Simon F. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon F. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon F. Campbell more than expected).

Fields of papers citing papers by Simon F. Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon F. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon F. Campbell. The network helps show where Simon F. Campbell may publish in the future.

Co-authorship network of co-authors of Simon F. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Simon F. Campbell. A scholar is included among the top collaborators of Simon F. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon F. Campbell. Simon F. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Júnior, Celso de Oliveira Rezende, Leonardo L. G. Ferreira, Adriano D. Andricopulo, et al.. (2021). 2-aminobenzimidazoles for leishmaniasis: From initial hit discovery to in vivo profiling. PLoS neglected tropical diseases. 15(2). e0009196–e0009196. 11 indexed citations
2.
Dessoy, Marco A., An Matheeussen, Louis Maes, et al.. (2020). Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents. RSC Medicinal Chemistry. 11(11). 1267–1274. 5 indexed citations
3.
Ryan, Eileen, Gong Chen, Karen L. White, et al.. (2016). Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans. European Journal of Medicinal Chemistry. 126. 929–936. 17 indexed citations
4.
Campbell, Simon F., et al.. (2005). Simon Campbell on the ups and downs of drug discovery and development. Drug Discovery Today. 10(4). 233–236. 1 indexed citations
5.
Hubbard, Simon J., Janet M. Thornton, & Simon F. Campbell. (1992). Substrate recognition by proteinases. Faraday Discussions. 93(93). 13–13. 14 indexed citations
6.
Campbell, Simon F.. (1991). Molecular Recognition and Drug Design. Química Nova. 14(3). 196–203. 2 indexed citations
7.
8.
9.
10.
Bell, Andrew, Simon F. Campbell, Peter Ellis, et al.. (1989). 2(1H)-Quinolinones with cardiac stimulant activity. 2. Synthesis and biological activities of 6-(N-linked, five-membered heteroaryl) derivatives. Journal of Medicinal Chemistry. 32(3). 575–583. 39 indexed citations
11.
Danilewicz, John C., Paul L. Barclay, I. T. Barnish, et al.. (1989). UK-69, 578, a novel inhibitor of EC 3.4.24.11 which increases endogenous ANF levels and is natriuretic and diuretic. Biochemical and Biophysical Research Communications. 164(1). 58–65. 53 indexed citations
12.
Bell, Andrew, Simon F. Campbell, David S. Morris, David A. Roberts, & Mark H. Stefaniak. (1989). 2(1H)-Quinolinones with cardiac stimulant activity. 3. Synthesis and biological properties of 6-imidazol-1-yl derivatives. Journal of Medicinal Chemistry. 32(7). 1552–1558. 13 indexed citations
13.
Bell, Andrew, et al.. (1989). 7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity. Journal of Medicinal Chemistry. 32(9). 2042–2049. 9 indexed citations
14.
Alker, David, et al.. (1989). Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives. Journal of Medicinal Chemistry. 32(10). 2381–2388. 25 indexed citations
15.
Arrowsmith, John, Simon F. Campbell, Peter E. Cross, Roger A. Burges, & Donald G. Gardiner. (1989). Long acting dihydropyridine calcium antagonists. 2. 2-[2-aminoheterocycloethoxy]methyl derivatives. Journal of Medicinal Chemistry. 32(3). 562–568. 16 indexed citations
16.
Campbell, Simon F., et al.. (1988). 2,4-Diamino-6,7-dimethoxyquinoline derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents. Journal of Medicinal Chemistry. 31(5). 1031–1035. 145 indexed citations
17.
Bell, Andrew, et al.. (1988). 2(1H)-Quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives. Journal of Medicinal Chemistry. 31(10). 2048–2056. 44 indexed citations
18.
Campbell, Simon F., et al.. (1988). 2,4-Diamino-6,7-dimethoxyquinazolines. 4. 2-[4-(Substituted oxyethoxy)piperidino] derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents. Journal of Medicinal Chemistry. 31(3). 516–520. 13 indexed citations
19.
Singh, Juswinder, Janet M. Thornton, M. Snarey, & Simon F. Campbell. (1987). The geometries of interacting arginine‐carboxyls in proteins. FEBS Letters. 224(1). 161–171. 89 indexed citations
20.
Campbell, Simon F., et al.. (1987). 2,4-Diamino-6,7-dimethoxyquinazolines. 3. 2-(4-heterocyclylpiperazin-1-yl) derivatives as .alpha.1-adrenoceptor antagonists and antihypertensive agents. Journal of Medicinal Chemistry. 30(10). 1794–1798. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Czarniecki Breakdown of academic impact, for papers by B. CASTRO Breakdown of academic impact, for papers by Bertrand Castro Breakdown of academic impact, for papers by Th. Wieland Breakdown of academic impact, for papers by David C. Pryde Breakdown of academic impact, for papers by David C. Rees Breakdown of academic impact, for papers by Thomas J. Perun Breakdown of academic impact, for papers by Zsolt Böcskei Breakdown of academic impact, for papers by H. C. J. OTTENHEIJM Breakdown of academic impact, for papers by Stephen W. Kaldor
Rankless by CCL
2026